Drug Discovery and Development Strategies for COVID-19

  • Aarajana Shrestha https://orcid.org/0000-0002-3047-6574
  • Tara Man Kadayat
Keywords: COVID-19, Drug Discovery and Development, Repurposed Drug

Abstract

COVID-19 Special Issue: Coronavirus Disease 2019 (COVID-19) has emerged as a global threat. Scientists and clinicians are endeavoring to find effective drugs and vaccines for this disease. This special issue of the Europasian Journal of Medical Sciences (EJMS) aims to cover the problems, solutions, and challenges of COVID-19 around the world. In this Editorial, EJMS Editors Aarajana Shrestha and Tara Man Kadayat highlight the processes of drug discovery and development and a brief overview of the current drug development strategies against COVID-19.

Author Biographies

Aarajana Shrestha, https://orcid.org/0000-0002-3047-6574

Editor, Europasian Journal of Medical Sciences; Drug Discovery Researcher, Institute for Drug Research, Postdoctoral Research Program, College of Pharmacy, Yeungnam University, Gyeongsan 38541, Republic of Korea

Tara Man Kadayat

Editor, Europasian Journal of Medical Sciences; Research Scientist, New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu 41061, Republic of Korea; Consultant Pharmacist, Integrated Pharmacy Program, Khas Health Group, Dhangadhi, Kailali, Nepal

Published
2020-06-10
How to Cite
Shrestha, A., & Kadayat, T. M. (2020). Drug Discovery and Development Strategies for COVID-19. Europasian Journal of Medical Sciences , 2(2), 1-5. https://doi.org/10.46405/ejms.v2i2.89